Authored
by Vipul Bhandari
Introduction
Keratoconus is a degenerative, non-inflammatory
corneal
disorder characterized by progressive stromal thinning and
ectasia.10-20% of keratoconus patients requires surgical
intervention in advanced stage in the form of either Penetrating
Keratoplasty (PK) or Deep Anterior Lamellar Keratoplasty [1].
Deep Anterior Lamellar Keratoplasty (DALK) is preferred over
PK due to less incidence of graft failure [2]. Visual outcome of
DALK surgery is comparable to PK, avoiding risk of endothelial
rejection. Endothelial cell loss was low and cell count was stable
after 6 months [3]. Watson et al. [4] compared DALK with PK.
Best corrected visual acuity, refractive results and complication
rates are similar after DALK and PK. Compared to PK, one of
the major advantages of DALK is normal endothelial cell counts
postoperatively. Comparatively DALK has endothelial cell loss of
1.2% at 2 years. Cell survival after DALK may be expected to be better
than PK [5]. In spite of refractive stability obtained during
the first years after PK for keratoconus, increasing astigmatism
thereafter suggests that there is a progression of the disease in
the host cornea [6]. Recurrent keratoconus following PK is rare
but has been described [7-8]. N Patel has reported the first case
of recurrent ectasia in a relatively new treatment option-deep
lamellar keratoplasty for keratoconus [9]. We in our study have
analysed post DALK patients for any such changes after two year
of follow up.
Material and Methods
Retrospective analysis 122 eyes of 71 patients who
underwent DALK for progressive keratoconus. Inclusion criteria
were patients who underwent DALK for keratoconus from 2011
to 2013 and those who completed 2 years of follow-up after
obtaining approval from institutional review board and ethical committee clearance. Exclusion criteria included all patients who
had any intra or post operative complications. Keratoconus was
diagnosed clinically based on slit lamp findings (stromal thinning,
Fleischer ring, Vogt’s striae) and keratometry, and was confirmed
by corneal topography and Pentacam. Preoperative evaluations
included uncorrected visual acuity (UCVA), best corrected visual
acuity (BCVA), slit lamp biomicroscopy, corneal topography
(Keratonscout), corneal pachymetry (CCT) (AL-2000; Tomey)
.None of the patients had previous history of refractive surgery.
DALK was done in all patients using Anwar a Teichmann bigbubble
technique [11]. All donor cornea had an endothelial count
greater than 2000 cells and clear stroma. All grafts were well
centered with an average graft size of 8-8.5mm and done by a
single surgeon. The donor cornea was fixed with interrupted 10–0
nylon sutures in all the patients. Patients received Dexoren-S
(dexamethasone sodium phosphate 0.1% and chloramphenicol
0.5%, warren excel, INDOCO) e/d 6 times per day for 1 month
followed by 4 times per day for 1 months then changed to
Lotepred 0.5%(Loteprednoletabonate ophthalmic suspension,
SUNpharma) e/d 4 times per day for 2 months followed by 2
times for 1 month followed by 1 time for 6 months. Follow-up
examinations were scheduled 1, 7 and 30 days and 3,6,9,12 and
24 months postoperatively and complete suture removal was
done after 6-18 months thereafter based on topography and
automated keratometry readings. Parameters analyzed were
UCVA, BCVA, Slit lamp findings, corneal topography, CCT and
stromal haze.
Clinical grading of stromal haze–
Grade 0-completelty clear cornea
Grade 0.5 for trace haze seen with careful oblique illumination
with slit lamp biomicroscopy.
Grade 1 for more prominent haze not interfering with
visibility of fine iris details.
Grade 2 for mild obscuration of iris details.
Grade 3 for moderate obscuration of iris details.
Grade 4 for complete opacification of stroma.
Grade 0-completelty clear cornea
Grade 0.5 for trace haze seen with careful oblique illumination
with slit lamp biomicroscopy.
Grade 1 for more prominent haze not interfering with
visibility of fine iris details.
Grade 2 for mild obscuration of iris details.
Grade 3 for moderate obscuration of iris details.
Grade 4 for complete opacification of stroma.
Statistical Analysis
Significance was assessed at 5 % level of significance. Paired
t-test was used to compare pre- and postoperative astigmatism
and BSCVA values and Chi-square test was used for comparison
of qualitative parameters
Results
A total of 122 eyes of 71 patients with progressive keratoconus
were operated. Mean age at the time of surgery was 26.2±7.8
(range 15-40) years. 31 eyes of 25 patients (25% of total) showed
topographic evidence of Central Island of flattening. It correlated
with slit lamp finding of sub epithelial haze of varying density. The
average onset of central sub epithelial haze was at 9-12 months
post DALK (Figure 1). Haze was more common in the younger
age below 25 years with 60% cases with stromal haze below 25
years of age, no sex association was noted. None of the patients
had bilateral involvement. The central haze progressed over time (Figure 2a & 2b) and was associated with thinning of the
cornea. These 31 eyes with stromal rejection (study group) were
compared with other eyes (91 eyes) with absence of thinning
or haze (control group). Mean UCVA was 0.7±0.3LogMAR in
control group while in study group it was 0.88±0.15LogMAR
(P < 0.005). Mean BSCVA in control group was 0.19±0.18LogMAR
while in study group it was 0.62±0.11LogMAR (P < 0.001). The
onset and progression of central flattening was associated with
corresponding decrease in UCVA and BCVA. Mean keratometry
in study group was K flat 40.81±1.41D and K steep 44.12±1.45
D while in control group it was K flat 45.38±2.72 D and K steep
44.12±1.45 D. Mean pachymetry reading in study group was
443.481±.45μm while in control group it was 535±16.45μm.
The pachymetry reading of the central cornea varied from 400μ
to 475μm and correlated with topographic finding of flattening
(Figure 3a & 3b) (Table 1). Pentacam images also showed central
flattening (Figure 4a & 4b). Anterior segment OCT also showed
stromal haze at periodic follow up (Figure 5a & 5b). No graft
surface complications were encountered.
Discussion
Mohammad Ali Javadi et al. [11] listed the causes of
decreased
vision after DALK. Which includednon-endothelial graft
rejection, astigmatism filamentary keratitis, vascularization.
Recurrence of keratoconus in a donor cornea has already been
described [12-14]. and may well be manifestation of the same
mechanisms that caused ectasia of the host cornea in the first
place. This could be due to degradative enzymes liberated by
abnormal host epithelium or infiltration of the graft by abnormal
host keratocytes that produce abnormal collagen [15-16]. One
speculative mechanism is failure to completely excise the cone
before PKP which may lead to progression of keratoconus in the
host tissue with possible involvement of the dono [17-18]. Feizi S
et al. [19] reported a case of recurrence of keratoconus in corneal
graft after DALK. Till now no study has shown the flattening of
graft with stromal haze in late post operative period. In our study,
inverse keratoconus was recorded in eyes after 2 years after
deep lamellar keratoplasty and this was confirmed both clinically
and topographically. Stromal rejection i.e, central haze, flattening
and thinning in the graft after DALK for keratoconus (Figure 4
& 5) may be chronic stromal rejection or progressive thinning
of cornea associated with disease process of keratoconus or due
to reduced corneal sensations. In contrast to PK, keratoconus
recurred a few years after DALK. Such earlier recurrence can be
attributed to several differences pertaining to the DALK surgical
technique. First, retained keratocytes in the stromal bed may
invade and replace donor tissue leading to recurrent keratoconus
much earlier than what is expected in PK. We previously
reported that even after successful big-bubble formation,
some posterior stroma containing abnormal keratocytes
remains in place [20]. Second, removal of DM from the donor cornea, a
common practice in DALK, can theoretically weaken
donor tissue. Although our comparison of graft biomechanical
properties between bare-DM DALK and PK in keratoconic eyes
failed to demonstrate a significant difference [21]. DM removal
may actually yield donor tissue with less strength resulting in
earlier manifestation of ectasia when keratoconus recurs in the
DALK graft. The inflammatory pathways activated following
DALK failure due to infection, in particular the metalloproteinase
system (gelatinolytic activity of stromal collagenase (matrix
metalloproteinase-1 (MMP-1)), may play an important part
through thinning of the stromal tissue [22].
Conclusion
In our study the pathogenesis of corneal haze, flattening and
thinning complication was unclear. Donor factors include the possibility of ectatic disease which may have been missed or
remained subclinical throughout the donor’s life. New screening
methods utilising the Orb scan are being explored looking at
the topography of donor corneas that could prevent potential
problems with using ectatic corneas if routinely employed
[23]. In summary, a central island of flattening after DALK with
associated decrease in the visual acuity can be a chronic stromal
rejection or progressive disease process of keratoconus for which
we need to further investigate.
For more
details JOJ Ophthalmology please click on:
https://juniperpublishers.com/jojo/classification.php
https://juniperpublishers.com/jojo/classification.php
To read more…Full Text in Juniper Publishers click on https://juniperpublishers.com/jojo/JOJO.MS.ID.555551.php
No comments:
Post a Comment